Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
07/17/2003 | WO2003057822A2 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
07/17/2003 | WO2003057722A2 Cyclic tetrapeptide compound and use thereof |
07/17/2003 | WO2003057696A1 Deazapurines and uses thereof |
07/17/2003 | WO2003057694A1 Method for producing scopine esters |
07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
07/17/2003 | WO2003057249A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
07/17/2003 | WO2003057229A1 Antiviral and antipyretic formulation and the preparation method thereof |
07/17/2003 | WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity |
07/17/2003 | WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases. |
07/17/2003 | WO2003057200A2 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
07/17/2003 | WO2003057198A1 Pharmaceutical formulations with modified release |
07/17/2003 | WO2003057196A1 Drug mixture with enhanced dissolution rate |
07/17/2003 | WO2003057194A1 Sterile filtered nanoparticule formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
07/17/2003 | WO2003057166A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
07/17/2003 | WO2003057149A2 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones |
07/17/2003 | WO2003057133A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
07/17/2003 | WO2003030827A3 Compositions for and methods of treating and preventing sirs/sepsis |
07/17/2003 | WO2003020325A3 Methods for sterilizing preparations containing albumin |
07/17/2003 | WO2003000896A3 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
07/17/2003 | WO2002076434A3 Nicotinic receptor agonists for the treatment of inflammatory diseases |
07/17/2003 | WO2002059286A3 Adenylate cyclases |
07/17/2003 | WO2002046190A3 Sulfonamido ether substituted imidazoquinolines |
07/17/2003 | WO2002026998A3 Hydrolases |
07/17/2003 | US20030134901 Lipoxin compounds and their use in treating cell proliferative disorders |
07/17/2003 | US20030134886 Pharmaceutically active compounds |
07/17/2003 | US20030134876 Inhibiting TNF alpha |
07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
07/17/2003 | US20030134873 8-phenyl-(1,2,4)triazolo(1,5-a)pyridin-2-yl)-benzamide derivatives |
07/17/2003 | US20030134865 Modulation of histone deacetylase |
07/17/2003 | US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease |
07/17/2003 | US20030134856 Method and structure for inhibiting activity of serine elastases |
07/17/2003 | US20030134855 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and ADHD |
07/17/2003 | US20030134854 Treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, neuroprotection, Parkinson's disease, and attention deficit hyperactivity disorder. |
07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
07/17/2003 | US20030134840 Novel compounds |
07/17/2003 | US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
07/17/2003 | US20030134805 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
07/17/2003 | US20030134796 Antithrombin for the prevention and therapy of vasculoproliferative disorders |
07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
07/17/2003 | US20030133988 Immunomodulation accomplished by administration of immunomodulatory polynucleotide/microcarrier complexes comprising 3-6 mer immunomodulatory oligonucleotides |
07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
07/17/2003 | US20030133925 Monobactam compositions and methods of use thereof |
07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
07/17/2003 | US20030133880 Powdery pharmaceutical compositions for inhalation |
07/17/2003 | CA2472585A1 Drug mixture with enhanced dissolution rate |
07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
07/17/2003 | CA2472151A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
07/17/2003 | CA2471957A1 Cyclic tetrapeptide compound and use thereof |
07/17/2003 | CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
07/17/2003 | CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
07/17/2003 | CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
07/16/2003 | EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
07/16/2003 | EP1327463A1 Gel comprising Cetirizine and Loratadine for topical application |
07/16/2003 | EP1327452A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
07/16/2003 | EP1327449A1 Remedies for ischemic diseases |
07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
07/16/2003 | EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
07/16/2003 | EP1326862A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
07/16/2003 | EP1326858A2 Piperidine compounds as anti-allergic |
07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
07/16/2003 | EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
07/16/2003 | EP1326642A2 Catecholamine pharmaceutical compositions and methods |
07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
07/16/2003 | EP1326612A1 Gatifloxacin pentahydrate |
07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
07/16/2003 | EP1326595A2 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
07/16/2003 | EP1326586A1 New pharmaceutical compositions containing epinastine and pseudoephedrine |
07/16/2003 | EP1326585A2 Method for producing powdery formulations |
07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
07/16/2003 | CN1430620A Macrolides compound |
07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |